Radiopharmaceutical agents have two components:

Radiopharmaceutical agents have two components:

• A. Detectors and Pharmaceuticals
• B. Radionuclides and Solvents
• C. Radioactive Sources and Imaging Agents
• D. Radionuclides and Pharmaceutical

Answer: (D)

Radiopharmaceuticals are designed with two essential parts: a radionuclide that emits the radiation used for detection or therapy, and a pharmaceutical carrier that directs that radiation to a specific biological target. The radionuclide provides the imaging signal (or therapeutic dose), while the pharmaceutical component determines where in the body the agent goes, how it interacts with tissues, and how long it stays there. This combination lets clinicians image particular organs or processes or deliver therapy precisely to targeted sites. For example, technetium-99m attached to a targeting molecule enables imaging of specific tissues, and lutetium-177 attached to a targeting peptide enables targeted radiotherapy. The other options don’t describe the two key pieces of a radiopharmaceutical: detectors are external equipment, solvents aren’t the functional partner in the agent, and “radioactive sources” isn’t the defined two-part construct used in practice.

Radiopharmaceuticals are designed with two essential parts: a radionuclide that emits the radiation used for detection or therapy, and a pharmaceutical carrier that directs that radiation to a specific biological target. The radionuclide provides the imaging signal (or therapeutic dose), while the pharmaceutical component determines where in the body the agent goes, how it interacts with tissues, and how long it stays there. This combination lets clinicians image particular organs or processes or deliver therapy precisely to targeted sites. For example, technetium-99m attached to a targeting molecule enables imaging of specific tissues, and lutetium-177 attached to a targeting peptide enables targeted radiotherapy. The other options don’t describe the two key pieces of a radiopharmaceutical: detectors are external equipment, solvents aren’t the functional partner in the agent, and “radioactive sources” isn’t the defined two-part construct used in practice.